FGFR1 mRNA and Protein Expression, not Gene Copy Number, Predict FGFR TKI Sensitivity across All Lung Cancer Histologies-Reference-Cited by-同舟云学术

FGFR1 mRNA and Protein Expression, not Gene Copy Number, Predict FGFR TKI Sensitivity across All Lung Cancer Histologies

Published:2014-04-25 Issue:12 Volume:20 Page:3299-3309
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Wynes Murry W.,Hinz Trista K.,Gao Dexiang,Martini Michael,Marek Lindsay A.,Ware Kathryn E.,Edwards Michael G.,Böhm Diana,Perner Sven,Helfrich Barbara A.,Dziadziuszko Rafal,Jassem Jacek,Wojtylak Szymon,Sejda Aleksandra,Gozgit Joseph M.,Bunn Paul A.,Camidge D. Ross,Tan Aik-Choon,Hirsch Fred R.,Heasley Lynn E.

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 138 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oncogene alterations in non-small cell lung cancer with FGFR1 amplification—novel approach to stratify patients who benefit from FGFR inhibitors;Translational Lung Cancer Research;2024-03

2. High-resolution genomic configuration of FGFR rearrangements dictates the therapeutic vulnerability of squamous cell lung cancers;Translational Lung Cancer Research;2024-02

3. Dual-Warhead Conjugate Based on Fibroblast Growth Factor 2 Dimer Loaded with α-Amanitin and Monomethyl Auristatin E Exhibits Superior Cytotoxicity towards Cancer Cells Overproducing Fibroblast Growth Factor Receptor 1;International Journal of Molecular Sciences;2023-06-14

4. Patient Selection Approaches in FGFR Inhibitor Trials—Many Paths to the Same End?;Cells;2022-10-10

5. Signaling pathways and targeted therapies in lung squamous cell carcinoma: mechanisms and clinical trials;Signal Transduction and Targeted Therapy;2022-10-05